Medical Device Importer Obligations Under the EU MDR

Specialist checking the label of a boxed patient monitor before placing it on the EU market

The MDR has applied since 26 May 2021 and sets out the duties of importers in Article 13. MDCG 2021-27, the MDCG questions and answers on Articles 13 and 14, dates from December 2021 and was revised in December 2023. Actor registration in EUDAMED has been mandatory since 28 May 2026 (European Commission).

Whoever first makes a non-EU device available in the EU is the importer, whatever the contract says. This article explains who the importer is, the checks before placing a device on the market, labelling and registration, ongoing duties, when an importer becomes the manufacturer, and short notes on Northern Ireland and the US.

Who is the importer

Under Article 2(33), an importer is a natural or legal person established in the EU who places on the market a device from a third country. Placing on the market means the first making available of a device in the EU (Article 2(28)).

According to MDCG 2021-27:

  • importer status is assessed per individual device, so one model can have several importers;

  • an EU distributor that buys directly from a non-EU supplier becomes the importer;

  • a logistics provider that only transports and stores the goods is normally not the importer;

  • an EU manufacturer that has its device produced outside the EU does not create an importer, because it places the device on the market itself;

  • one person cannot be both importer and distributor for the same individual device, but an authorised representative can also be the importer.

In our view, settle the roles before the first shipment. Our article on EU medical device distributor regulations covers the distributor side.

Checks before placing on the market

Check MDR How to verify
CE marking and EU declaration of conformity Art. 13(2)(a) Check the mark on the device and obtain the declaration for the same model
Manufacturer identified and authorised representative designated Art. 13(2)(b); Art. 11 Match the names on the label and declaration; confirm the authorised representative in EUDAMED
Labelling and instructions for use Art. 13(2)(c) Inspect the label and IFU on the device as received
UDI assigned, where applicable Art. 13(2)(d); Art. 27 Check the UDI carrier on the device and packaging

Sources: MDR Article 13(2); MDCG 2021-27 Rev.1.

If the importer considers or has reason to believe that a device is not in conformity, it must not place it on the market until conformity is restored, and must inform the manufacturer and authorised representative. If the device presents a serious risk or is falsified, it must also inform the competent authority of the Member State where it is established.

In our view, these checks cannot be delegated upstream. Keep your own dated evidence per shipment. Where the manufacturer is outside the EU, MedQAIR's Digital AR service covers the authorised representative role the importer checks.

Labelling and registration

Under Article 13(3), the importer's name, registered trade name or registered trade mark, registered place of business and contact address must appear on the device, its packaging or an accompanying document, without obscuring the manufacturer's label. According to MDCG 2021-27, this applies at the first making available in the EU, a sticker or leaflet is acceptable, and the details should be on the smallest saleable package. The work can be subcontracted, but the responsibility stays with the importer.

Timing Duty MDR
Before placing on the market Register as an actor in EUDAMED Art. 31(1)
On registration Single registration number (SRN) issued Art. 31(2)
Before placing on the market Verify the device is registered and add the importer's details Art. 13(4)
Within two weeks of placing on the market Verify the manufacturer or authorised representative entered the device data, and report gaps Art. 30(3)
Within one week of a change Update the registration data Art. 31(4)
Within one year, then every second year Confirm the registration data Art. 31(5)

Source: MDR Articles 13, 30 and 31.

Our EUDAMED and UDI registration checklist covers the manufacturer's side of registration.

Ongoing duties

Duty MDR Evidence to keep
Storage and transport conditions that preserve conformity Art. 13(5) Records of storage and transport conditions
Register of complaints, non-conforming devices, recalls and withdrawals Art. 13(6) The register, available on request
Cooperation on corrective action; serious risk reported to authorities and notified body Art. 13(7) Dated notifications
Forward complaints and incident reports to the manufacturer and authorised representative Art. 13(8) Dated forwarding records
Copies of the declaration of conformity and certificates Art. 13(9) Kept for the Art. 10(8) period: at least 10 years after the last device, 15 years for implantables
Provide samples or access on request Art. 13(10) A procedure for providing them

Sources: MDR Article 13; MDCG 2021-27 Rev.1.

The MDR does not prescribe a format for any of these records. In our view, design the evidence for the retention period, not just the shipment. Sharing the declaration of conformity and device data with the manufacturer and authorised representative is easier from one shared source; MDIS for importers is built for that, and our article on MDIS for ARs and importers explains how.

When the importer becomes the manufacturer

Under Article 16(1), an importer takes on the manufacturer's obligations if it:

  • makes a device available under its own name or trade mark, unless an agreement identifies the manufacturer on the label and keeps the manufacturer responsible;

  • changes the intended purpose of a device already on the market; or

  • modifies a device in a way that may affect compliance.

Translation and repackaging are not modifications for this purpose (Article 16(2)), but they come with their own duties under Article 16(3) and (4), including notifying the manufacturer 28 days in advance.

In our view, Article 16 is the main trap for importers. A request for private labelling or a new intended purpose is a regulatory decision, not just a commercial one.

Northern Ireland and the US

Northern Ireland: according to the MHRA, the MDR applies. Importers, including those bringing devices from Great Britain into Northern Ireland, register as actors in EUDAMED, and their details can appear on an accompanying document such as an invoice.

United States: initial importers register their establishment and, for listing, provide the manufacturer's name and address (21 CFR 807.20). Under 21 CFR 803.40, importers report deaths and serious injuries to FDA and the manufacturer, and malfunctions to the manufacturer, within 30 calendar days.

A hypothetical example

Hypothetical example: a Dutch company imports a US-made patient monitor with embedded software. The US manufacturer has an EU authorised representative.

  1. Role: the Dutch company is the importer, because it first places the monitor on the EU market.

  2. Checks: it verifies the CE marking, declaration of conformity, label and UDI, and confirms the authorised representative in EUDAMED.

  3. Labelling: it adds a sticker with its details to the smallest saleable package.

  4. Registration: it holds an SRN before the first shipment and completes the two-week check under Article 30(3).

  5. Records: it keeps the complaints register and a copy of the declaration of conformity.

  6. Later: if it rebrands the monitor under its own name, it becomes the manufacturer under Article 16(1).

Conclusion

Importer status is decided per device. The Article 13(2) checks, labelling and registration come before the first shipment; the two-week registration check and the ongoing duties follow. Article 16 can turn an importer into a manufacturer.

In our view, settle roles early, keep dated evidence per shipment, and treat private labelling as a regulatory decision.

If you need help with economic operator roles, our economic operators team can help, or contact MedQAIR.

Frequently asked questions

Is a distributor buying from a US supplier an importer?

Yes, if it is the first to make the device available in the EU. MDCG 2021-27 assesses this per device.

Can the authorised representative also be the importer?

Yes. One person can hold both roles, but the duties are assessed separately. Our article on the authorised representative covers the mandate.

Must the importer's address be on the device itself?

No. Article 13(3) allows it on the device, its packaging or an accompanying document, without obscuring the manufacturer's label.

Do importers register in EUDAMED?

Yes. Importers register as actors and receive an SRN. According to MDCG 2021-27, distributors do not register in EUDAMED.

How long must importers keep the declaration of conformity?

For at least 10 years after the last device covered has been placed on the market, or 15 years for implantable devices.

Latest Blogs

November 17, 2026

The MDR has applied since 26 May 2021 and sets out the duties of importers in Article 13. MDCG 2021-27,

November 16, 2026

The MDR has applied since 26 May 2021. In the US, the Quality Management System Regulation (QMSR) took effect on

November 15, 2026

The MDR has applied since 26 May 2021, with stricter designation requirements for notified bodies than under the directives. Implementing

logo

Unlock Your Quick Guide to AI Act
Compliance!

Explore AI-enabled SaMD requirements with our easy step-by-step guide.

Cookies help us improve your experience on our website. By using our site, you consent to the use of cookies as described in this policy.